Director of Diamedica Therapeutics Inc. (NASDAQ:DMAC), Giuffre Randall Michael, buys 15,000 shares worth $63,912

According to Diamedica Therapeutics Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 23 04:22 PM, company Director, Giuffre Randall Michael disclosed buying 15,000 shares at a cost of $4.26. At the time of this transaction (Nov 20), this trade was worth $63,912 in total. As of Nov 20, Giuffre Randall Michael now owns 108,588 shares in total worth about $451,726.08.

For the last few recent trades made by Diamedica Therapeutics Inc. (NASDAQ:DMAC) Director, Giuffre Randall Michael, we have the following information:

Posted by George Daniels on Monday November 23 2020, 6:12 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0